| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.24 | 3e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 8e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |